2025 annual financial data
Myriad Genetics 2025 Operating margin
Direct answer
Operating margin was -8.22%.
Operating income was -67,800,000 USD and net income was -365,900,000 USD.
Operating cash flow was 1,800,000 USD.
Get free Myriad Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 824,500,000 USD
- Operating income
- -67,800,000 USD
- Net income
- -365,900,000 USD
- Operating cash flow
- 1,800,000 USD